HomeCompareCIMDF vs JNJ

CIMDF vs JNJ: Dividend Comparison 2026

CIMDF yields 5.79% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIMDF wins by $14251.86M in total portfolio value
10 years
CIMDF
CIMDF
● Live price
5.79%
Share price
$2.00
Annual div
$0.12
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14251.89M
Annual income
$13,793,912,290.49
Full CIMDF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CIMDF vs JNJ

📍 CIMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIMDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIMDF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIMDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIMDF
Annual income on $10K today (after 15% tax)
$491.81/yr
After 10yr DRIP, annual income (after tax)
$11,724,825,446.92/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CIMDF beats the other by $11,724,821,409.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIMDF + JNJ for your $10,000?

CIMDF: 50%JNJ: 50%
100% JNJ50/50100% CIMDF
Portfolio after 10yr
$7125.96M
Annual income
$6,896,958,520.19/yr
Blended yield
96.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CIMDF
No analyst data
Altman Z
-0.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIMDF buys
0
JNJ buys
0
No recent congressional trades found for CIMDF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIMDFJNJ
Forward yield5.79%2.14%
Annual dividend / share$0.12$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$14251.89M$30.5K
Annual income after 10y$13,793,912,290.49$4,749.88
Total dividends collected$14220.09M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIMDF vs JNJ ($10,000, DRIP)

YearCIMDF PortfolioCIMDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,857$1,157.20$10,594$274.49+$1.3KCIMDF
2$15,252$2,564.70$11,294$360.69+$4.0KCIMDF
3$22,486$6,166.30$12,133$476.91+$10.4KCIMDF
4$41,052$16,992.46$13,156$635.42+$27.9KCIMDF
5$101,913$57,987.04$14,432$854.61+$87.5KCIMDF
6$378,119$269,072.40$16,056$1,162.76+$362.1KCIMDF
7$2,270,600$1,866,012.72$18,175$1,604.53+$2.25MCIMDF
8$23,374,171$20,944,628.33$21,009$2,252.68+$23.35MCIMDF
9$428,019,025$403,008,662.31$24,911$3,229.73+$427.99MCIMDF
10$14,251,892,647$13,793,912,290.49$30,458$4,749.88+$14251.86MCIMDF

CIMDF vs JNJ: Complete Analysis 2026

CIMDFStock

CIMB Group Holdings Berhad provides various banking products and services in Malaysia and internationally. The company's Consumer Banking segment offers conventional and Islamic financial products and services, such as residential and non-residential property loans, secured personal loans, motor vehicle financing, credit cards, unsecured personal financing, wealth management, bancassurance, remittance and foreign exchange, deposits, and internet banking services to individual customers. Its Commercial Banking segment provides banking credit facilities, trade financing, cash management, remittance and foreign exchange, and general deposit products, as well as an online business banking platform to small and medium-scale enterprises, and mid-sized corporations. The company's Wholesale Banking segment offers client coverage marketing and delivering solutions; financial advisory services on issuance of equity and equity-linked products, debt restructuring, initial public offerings, secondary offerings, and general corporate advisory; conventional and Islamic funding solutions covering trade, working capital line, capital expenditure, leveraging, merger and acquisition, leveraged, and project financing products; and holistic funding solutions, including cash management, trade finance, foreign exchange, custody and corporate loans, derivatives, structured products, and debt capital. This segment also engages in the treasury activities and services comprising foreign exchange, money market, derivatives, and capital market trading instruments; transaction banking and broking services; and wealth management solutions, as well as investment, securities financing, and trust services. It operates through 630 retail branches and 7,652 self-service customer access points in 15 countries. The company was founded in 1924 and is headquartered in Kuala Lumpur, Malaysia.

Full CIMDF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CIMDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIMDF vs SCHDCIMDF vs JEPICIMDF vs OCIMDF vs KOCIMDF vs MAINCIMDF vs ABBVCIMDF vs MRKCIMDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.